Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04596384 · ClinicalTrials.gov registry record · NA

Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery

A NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
398
Enrollment target
3
Study locations

NCT04596384 is a NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 398 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04596384, a NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
398 participants
Enrollment target
3
Study locations

Study Summary

This phase III trial compares a home-based telemonitoring program that collects symptom and daily step information to surgeon only care in improving recovery and stopping complications within 30 days after surgery in patients with gastrointestinal, genitourinary, or gynecologic cancer who are scheduled to undergo abdominal surgery. Patients may experience a decrease in functional capacity and experience symptoms like pain and fatigue after surgery, and this may change their ability to walk and function. Home-based telemonitoring of patient symptoms and their ability to walk and function after surgery may help doctors and nurses find and treat problems early, which may improve the patient's recovery and lower the number of complications after surgery.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Medical Device Usage and Evaluation
  • OTHER Best Practice
  • PROCEDURE Functional Assessment
  • PROCEDURE Nutritional Assessment

Study Locations (3)

California

  • City of Hope Comprehensive Cancer Center - Duarte
  • City of Hope Antelope Valley - Lancaster
  • City of Hope South Pasadena - South Pasadena

Trial Details

FieldValue
Enrollment Target 398 participants
Start Date 2021-02-16
Est. Completion 2026-11-30
Phase NA

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT04596384

The ClinicalTrials.gov registry entry for NCT04596384 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 398 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04596384 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04596384 about?

NCT04596384 is a clinical study titled "Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery". This phase III trial compares a home-based telemonitoring program that collects symptom and daily step information to surgeon only care in improving recovery and stopping complications within 30 days after surgery in patients with gastrointestinal, genitourinary, or gynecologic cancer who are schedu...

What is the current status of trial NCT04596384?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 398 participants. The study started on 2021-02-16. Estimated completion is 2026-11-30.

What conditions does trial NCT04596384 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Malignant Female Reproductive System Neoplasm, Genitourinary System Carcinoma, Digestive System Carcinoma.

What interventions are being tested in trial NCT04596384?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER), Functional Assessment (PROCEDURE), Nutritional Assessment (PROCEDURE).

Who is sponsoring clinical trial NCT04596384?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04596384 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.